Insights from nanomedicine into chloroquine efficacy against COVID-19.
Identifieur interne : 000090 ( PubMed/Corpus ); précédent : 000089; suivant : 000091Insights from nanomedicine into chloroquine efficacy against COVID-19.
Auteurs : Tony Y. Hu ; Matthew Frieman ; Joy WolframSource :
- Nature nanotechnology [ 1748-3395 ] ; 2020.
DOI: 10.1038/s41565-020-0674-9
PubMed: 32203437
Links to Exploration step
pubmed:32203437Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Insights from nanomedicine into chloroquine efficacy against COVID-19.</title>
<author><name sortKey="Hu, Tony Y" sort="Hu, Tony Y" uniqKey="Hu T" first="Tony Y" last="Hu">Tony Y. Hu</name>
<affiliation><nlm:affiliation>Center for Cellular and Molecular Diagnostics, Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA. tonyhu@tulane.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Frieman, Matthew" sort="Frieman, Matthew" uniqKey="Frieman M" first="Matthew" last="Frieman">Matthew Frieman</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA. mfrieman@som.umaryland.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolfram, Joy" sort="Wolfram, Joy" uniqKey="Wolfram J" first="Joy" last="Wolfram">Joy Wolfram</name>
<affiliation><nlm:affiliation>Department of Biochemistry and Molecular Biology, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32203437</idno>
<idno type="pmid">32203437</idno>
<idno type="doi">10.1038/s41565-020-0674-9</idno>
<idno type="wicri:Area/PubMed/Corpus">000090</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000090</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Insights from nanomedicine into chloroquine efficacy against COVID-19.</title>
<author><name sortKey="Hu, Tony Y" sort="Hu, Tony Y" uniqKey="Hu T" first="Tony Y" last="Hu">Tony Y. Hu</name>
<affiliation><nlm:affiliation>Center for Cellular and Molecular Diagnostics, Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA. tonyhu@tulane.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Frieman, Matthew" sort="Frieman, Matthew" uniqKey="Frieman M" first="Matthew" last="Frieman">Matthew Frieman</name>
<affiliation><nlm:affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA. mfrieman@som.umaryland.edu.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Wolfram, Joy" sort="Wolfram, Joy" uniqKey="Wolfram J" first="Joy" last="Wolfram">Joy Wolfram</name>
<affiliation><nlm:affiliation>Department of Biochemistry and Molecular Biology, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Nature nanotechnology</title>
<idno type="eISSN">1748-3395</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32203437</PMID>
<DateRevised><Year>2020</Year>
<Month>03</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1748-3395</ISSN>
<JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year>
<Month>Mar</Month>
<Day>23</Day>
</PubDate>
</JournalIssue>
<Title>Nature nanotechnology</Title>
<ISOAbbreviation>Nat Nanotechnol</ISOAbbreviation>
</Journal>
<ArticleTitle>Insights from nanomedicine into chloroquine efficacy against COVID-19.</ArticleTitle>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/s41565-020-0674-9</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hu</LastName>
<ForeName>Tony Y</ForeName>
<Initials>TY</Initials>
<AffiliationInfo><Affiliation>Center for Cellular and Molecular Diagnostics, Department of Biochemistry and Molecular Biology, Tulane University School of Medicine, New Orleans, LA, USA. tonyhu@tulane.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Frieman</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA. mfrieman@som.umaryland.edu.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Wolfram</LastName>
<ForeName>Joy</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Department of Biochemistry and Molecular Biology, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Physiology and Biomedical Engineering, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Transplantation, Mayo Clinic, Jacksonville, FL, USA. wolfram.joy@mayo.edu.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, USA. wolfram.joy@mayo.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>DODW8IXWH1910926</GrantID>
<Agency>U.S. Department of Defense (United States Department of Defense)</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>R01HD090927</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>R01AI122932</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>R01AI113725</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>R21AI126361</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>R21AI52318</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency>
<Country></Country>
</Grant>
<Grant><GrantID>R21EB026347</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>23</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>Nat Nanotechnol</MedlineTA>
<NlmUniqueID>101283273</NlmUniqueID>
<ISSNLinking>1748-3387</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>3</Month>
<Day>24</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>aheadofprint</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32203437</ArticleId>
<ArticleId IdType="doi">10.1038/s41565-020-0674-9</ArticleId>
<ArticleId IdType="pii">10.1038/s41565-020-0674-9</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000090 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000090 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= CovidV2 |flux= PubMed |étape= Corpus |type= RBID |clé= pubmed:32203437 |texte= Insights from nanomedicine into chloroquine efficacy against COVID-19. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:32203437" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CovidV2
This area was generated with Dilib version V0.6.33. |